Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Topiderm is a Belgian pharmaceutical company specializing in the development and manufacture of dermatological products and medicinal skin care bases. Founded in 1987 and acquired by Fagron in 2008, the company is a recognized leader in providing high-quality vehicles for pharmaceutical compounding and finished topical treatments. Their portfolio includes a wide range of standardized creams, ointments, and lotions designed to treat conditions such as eczema, psoriasis, and chronic dry skin. Topiderm operates as a specialized unit within the Fagron Group, leveraging its expertise in galenic formulations to serve pharmacies and healthcare providers globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Topiderm.